MiniMed Group (MMED) vs West Pharmaceutical Services (WST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
West Pharmaceutical Services is the larger company by market cap ($25.57 billion vs $5.57 billion), about 4.6 times the size, while MiniMed Group is growing revenue faster (+14.3% vs +6.3%). On valuation, MiniMed Group trades at a lower forward P/E (31.1x vs 36.3x for West Pharmaceutical Services). West Pharmaceutical Services pays a dividend yielding 0.24%, while MiniMed Group does not currently pay one.
West Pharmaceutical Services converts more of its revenue into profit, with a net margin of 16.1% versus -10.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMED | WST |
|---|---|---|
| Share price | $19.80 | $363.27 |
| Market cap | $5.57B | $25.57B |
| 1-day change | +3.61% | -0.88% |
| YTD return | — | +32.03% |
| 1-year return | — | +35.58% |
| 5-year return | — | -10.26% |
| P/E ratio (TTM) | — | 46.51 |
| Forward P/E | 31.07 | 36.35 |
| EPS (TTM) | $-1.53 | $7.81 |
| Dividend yield | 0.00% | 0.24% |
| Annual dividend | $0.00 | $0.87 |
| Revenue (latest FY) | $3.10B | $3.07B |
| Revenue growth (YoY) | +14.25% | +6.25% |
| Net income (latest FY) | $-333.00M | $493.70M |
| Gross margin | 54.16% | 35.91% |
| Operating margin | -6.13% | 19.03% |
| Net margin | -10.74% | 16.06% |
| 52-week high | $24.43 | $386.00 |
| 52-week low | $10.65 | $223.83 |
| Distance from 52-week high | -18.95% | -5.89% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +24.70% | +13.14% |
| Average volume | 2.48M | 625.67K |
| Shares outstanding | 281.35M | 70.38M |
| Employees | 8,000 | 10,800 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- West Pharmaceutical Services is about 4.6 times larger than MiniMed Group by market value ($25.57B vs $5.57B).
- West Pharmaceutical Services is more profitable, keeping 16.1 cents of every revenue dollar as net income versus -10.7 cents for MiniMed Group.
- MiniMed Group grew revenue faster in its latest fiscal year (+14.25% vs +6.25%).
About MiniMed Group
MMED stock →MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
Health Care · Medical/Dental Instruments · 8,000 employees
About West Pharmaceutical Services
WST stock →West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 10,800 employees
MMED vs WST FAQ
Which is bigger, MiniMed Group or West Pharmaceutical Services?
West Pharmaceutical Services (WST) is larger, with a market capitalization of $25.57B compared with $5.57B for MiniMed Group (MMED).
Which pays a higher dividend, MiniMed Group or West Pharmaceutical Services?
West Pharmaceutical Services pays a dividend yielding 0.24%, while MiniMed Group does not currently pay a regular dividend.
Are MiniMed Group and West Pharmaceutical Services in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.